Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression

Journal of Psychiatric Research

Volumn 38, Issue 2, 2004, Pages 129-136

  Held, K ^a   Kunzel H ^a   Ising, M ^a   Schmid, D A ^a   Zobel, A ^a   Murck, H ^a   Holsboer, F ^a   Steiger, A ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

CRH 1 receptor antagonist; CRH overactivity; Depression; R 121919; Sleep

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; PYRIMIDINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; HORMONE ACTION; HUMAN; MALE; PRIORITY JOURNAL; SLEEP; SLOW WAVE SLEEP; TREATMENT OUTCOME; DRUG ANTAGONISM; ELECTROENCEPHALOGRAPHY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER;

ADMINISTRATION, ORAL; ADULT; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIMIDINES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 1642578880     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(03)00076-1     Document Type: Article

References (35)

1. Bohlhalter S., Murck H., Holsboer F., Steiger A. Cortisol enhances non-REM sleep and growth hormone secretion in elderly subjects. Neurobiology of Aging. 18:1997;423-429.
2. Born J., De Kloet E.R., Wenz H., Kern W., Fehm H.L. Gluco- and antimineralocorticoid effects on human sleep. a role of central corticosteroid receptors American Journal of Physiology. 260:1991;E183-E188.
3. Dorsey C.M., Lukas S.E., Cunningham S.L. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology. 14:1996;437-442.
4. Ehlers C.L., Kupfer D.J. Hypothalamic peptide modulation of EEG sleep in depression. a further application of the S-process hypothesis Biological Psychiatry. 22:1987;513-517.
5. Ehlers C.L., Reed T.K., Henriksen S.J. Effects of corticotropin- releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology. 42:1986;467-474.
6. Friess E., von Bardeleben U., Wiedemann K., Lauer C., Holsboer F. Effects of pulsatile cortisol infusion on sleep-EEG and nocturnal growth hormone release in healthy men. Journal of Sleep Research. 3:1994;73-79.
7. Giles D.E., Etzel B.A., Reynolds C.F. 3., Kupfer D.J. Stability of polysomnographic parameters in unipolar depression: a cross-sectional report. Biological Psychiatry. 25:1989;807-810.
8. Gonzalez M.M., Valatx J.L. Effect of intracerebroventricular administration of alpha-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus. Journal of Sleep Research. 6:1997;164-170.
9. Guldner J., Schier T., Friess E., Colla M., Holsboer F., Steiger A. Reduced efficacy of growth hormone-releasing hormone in modulating sleep endocrine activity in the elderly. Neurobiology of Aging. 18:1997;491-495.
10. Hemmeter U., Hatzinger M., Brand S., Holsboer-Trachsler E. Polysomnographic assessment of long term course of major depression. relationship to response and recurrencerates Somnologie. 6(Suppl. 1):2002;34-35.
11. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety [Review]. Journal of Psychiatric Research. 33:1999;181-214.
12. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
13. Holsboer F., von Bardeleben U., Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology. 48:1988;32-38.
14. Jahn H., Wiedemann K., Steiger A. Effects of metyrapone treatment upon hormonal secretion and sleep. European Neuropsychopharmacology 6 (Suppl. 3). 1996;175.
15. Keck M., Welt T., Wigger A. The anxiolytic effect of the CRH (1) receptor antagonist R 121919 depends on innate emotinality in rats. European Journal of Neuroscience. 13:2001;373-380.
16. Krueger J.M., Obál F. Jr. Growth hormone-releasing hormone and interleukin-1 in sleep regulation. FASEB Journal. 7:1993;645-652.
17. Künzel H., Murck H., Held K., Ziegenbein M., Steiger A. Effects of reboxetine on the sleep EEG of patients with depression. Biological Psychiatry. 47(8):2000;256. Suppl. S.
18. Lancel M., Müller-Preuss P., Wigger A., Landgraf R., Holsboer F. The CRH 1 receptor antagonist R121919 attenuates stress-elicited sleep disturbances in rats, particularly in those with high innate anxiety. Journal of Psychiatric Research. 36(4):2001;197-208.
19. Lauer C., Riemann D., Wiegand M., Berger M. From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biological Psychiatry. 29:1991;979-993.
20. Liebsch G., Landgraf R., Engelmann M., Lörscher P., Holsboer F. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisence oligodeoxy-nucleotides into the rat brain. Journal of Psychiatric Research. 33:1999;153-163.
21. Marrosu F., Gessa G.L., Giagheddu M., Fratta W. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Research. 515:1990;315-318.
22. Opp M., Obál F. Jr., Krueger J.M. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. American Journal of Physiology. 257:1989;R528-R535.
23. Opp M.R. Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking. Advances in Neuroimmunology. 5:1995;127-143.
24. Opp M.R. Rat strain differences suggest a role for corticotropin- releasing hormone in modulating sleep. Physiology & Behavior. 63:1997;67-74.
25. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacological Reviews. 43:1991;425-473.
26. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. 1968;US Department of Health, Education & Welfare, Neurological Information Network, Bethesda, MD.
27. Reynolds C.F. 3., Kupfer D.J. Sleep research in affective illness: state of the art circa 1987. Sleep. 10:1987;199-215.
28. Smith R.G. Unifying mechanism of a non-GHRH growth hormone secretagogue's action. Bercu B.B., Walker R.F. Growth hormone secretagogues in clinical practice. 1998;37-56 Marcel Dekker Inc, New York.
29. Steiger A. Sleep and the hypothalamo-pituitary-adrenocortical system. Sleep Medicine Reviews. 6:2002;125-138.
30. Steiger A., Holsboer F. Neuropeptides and human sleep. Sleep. 20:1997;1038-1052.
31. A-receptor modulation. Brain Research. 615:1993;267-274.
32. Steiger A., von Bardeleben U., Herth T., Holsboer F. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. Journal of Affective Disorders. 16:1989;189-195.
33. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K.et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics. 19:1998;162-166.
34. Vogel G.W., Buffenstein A., Minter K., Hennessey A. Drug effects on REM sleep and on endogenous depression. Neuroscience & Biobehavioral Reviews. 14:1990;49-63.
35. Zobel A.W., Nickel T., Künzel H.E., Ackl N., Sonntag A., Ising M.et al. effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression. the first 20 patients treated Journal of Psychiatric Research. 34:2000;171-181.